Skip to main content

MagForce's Nano-Cancer Therapy

The current approval covers the treatment of brain tumors only and studies in prostate cancer, esophageal cancer and pancreatic cancer are underway. Press release: MagForce Nanotechnologies AG receives European regulatory approval for

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino